Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specializing in the advancement of the cell and gene therapy industry, today announced a collaboration to demonstrate universal automation of CGT manufacturing.
Study finds a subset of artificial heart patients can regenerate heart muscle
A research team co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart Center found that a subset of
December 21, 2024